|
140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com
| |||
FIRM / AFFILIATE OFFICES | ||||
April 15, 2021 |
Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan |
Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. | ||
VIA EDGAR AND HAND DELIVERY |
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Dillon Hagius and Ada D. Sarmento
Re: | Biomea Fusion, Inc. |
Registration Statement on Form S-1 |
Publicly filed on March 26, 2021 |
File No. 333-254793 |
Ladies and Gentlemen:
On behalf of Biomea Fusion, Inc. (the Company or Biomea), we are hereby filing Amendment No. 2 (Amendment No. 2) to the Registration Statement on Form S-1 (Registration Statement). The Company previously filed a Registration Statement on Form S-1 on March 26, 2021 and Amendment No. 1 to the Registration Statement on April 12, 2021, in each case, with the U.S. Securities and Exchange Commission (the Commission). Amendment No. 2 has been revised to reflect the Companys responses to the comment letter received on April 15, 2021 from the staff of the Commission (the Staff).
For ease of review, we have set forth below each of the numbered comments of your letter in bold type followed by the Companys responses thereto.
April 15, 2021
Page 2
Registration Statement on Form S-1
Prospectus Summary
Overview, page 1
1. | We note that you have revised this section to include an additional table depicting your active discovery programs in response to prior comment 1. Please remove this additional table from the Prospectus Summary. We will not object to a narrative description in the Prospectus Summary that summarizes this table. |
Response: The Company acknowledges the Staffs comment and advises the SEC that it has revised pages 2, 109 and 115 of Amendment No. 2 accordingly.
* * *
April 15, 2021
Page 3
We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (415) 395-8198 or by fax at (650) 463-2600 with any questions or comments regarding this correspondence.
Very truly yours,
/s/ Miles P. Jennings
Miles P. Jennings
of LATHAM & WATKINS LLP
cc: | Thomas Butler, Biomea Fusion, Inc. |
Rainer (Ramses) Erdtmann, Biomea Fusion, Inc. |
Brian Cuneo, Latham & Watkins LLP |
Charles Kim, Cooley LLP |
Jonie Kondracki, Cooley LLP |